Who are placebo like amitriptyline's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Placebp, Placebo matching Tamsulosine Arrow LP, Gabapentin, Etoricoxib, Sugar pill, Matching placebo to Aliskiren, Matching placebo to Ramipril, Placebo matching with Metformin IR.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/placebo-like-amitriptyline.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

placebo like amitriptyline — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

placebo like amitriptyline (placebo like amitriptyline) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Placebo. Area: Psychiatry / Neurology.

marketed Placebo Psychiatry / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

placebo like amitriptyline (placebo like amitriptyline) — Tehran University of Medical Sciences. This is a placebo formulation designed to mimic amitriptyline, a tricyclic antidepressant that blocks reuptake of norepinephrine and serotonin.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
placebo like amitriptyline TARGET	placebo like amitriptyline	Tehran University of Medical Sciences	marketed	Placebo
Placebp	placebp	Pfizer	marketed	Placebo	None	Not applicable
Placebo matching Tamsulosine Arrow LP	Placebo matching Tamsulosine Arrow LP	Pierre Fabre Medicament	marketed	Placebo (matching formulation)
Gabapentin, Etoricoxib, Sugar pill	Gabapentin, Etoricoxib, Sugar pill	Meir Medical Center	marketed	Combination analgesic (gabapentinoid + selective COX-2 inhibitor + placebo)	Alpha-2-delta calcium channel subunit (gabapentin); COX-2 (etoricoxib)
Matching placebo to Aliskiren	Matching placebo to Aliskiren	Novartis	marketed	Placebo (matching Aliskiren, a direct renin inhibitor)
Matching placebo to Ramipril	Matching placebo to Ramipril	Novartis	marketed	Placebo (matching formulation for ACE inhibitor)
Placebo matching with Metformin IR	Placebo matching with Metformin IR	Bristol-Myers Squibb	marketed	Placebo (trial formulation); comparator is biguanide

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Placebo class)

Pfizer · 1 drug in this class
Tehran University of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). placebo like amitriptyline — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-like-amitriptyline. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing